Medical iSight (UK) Ltd.

Medical iSight (UK) Ltd. is a United Kingdom-based medical technology company headquartered in London. It is building an Extended Reality (XR) and Artificial Intelligence software platform intended for minimally invasive surgical procedures. The company's core offering, XRAI, is designed to give interventionalists and surgeons real-time, image-based guidance and crystal-clear 3D visualisation of patient anatomy during complex vascular procedures. The platform combines several technical capabilities: segmentation, soft tissue deformation and registration algorithms; tool tracking with stated accuracy within 0.5 mm; a kinematic database of surgical techniques; measurable quality-improvement benchmarking; and the curation of proprietary data sets that the company describes as developing significant and valuable intellectual property. According to the company, XRAI is intended to deliver better outcomes for patients, improve throughput in the operating room, reduce the frequency of adverse events, and give surgeons improved situational awareness and decision support. Medical iSight's initial clinical focus is stroke, which it describes as the second leading cause of disability and the fourth leading cause of death worldwide. The company says it is working with leading neuro-interventionalists to enhance mechanical thrombectomy, the procedure that retrieves blood clots from vessels in the brain that cause a stroke. The company believes XRAI can reduce adverse surgical events, improve theatre time by at least 30%, and significantly reduce the cognitive load for surgeons. Beyond stroke, the company states that XRAI has numerous applications across a variety of medical disciplines. Medical iSight has received visibility in the wider technology industry: an extract from NVIDIA CEO Jensen Huang's opening video for his keynote speech at CES 2025 included a 10-second clip of XRAIneuro at the start. The company is privately held and, as of the available evidence, does not disclose a parent company, founder, or founding year in the supplied sources.

Medical iSight (UK) Ltd. is a company based in London, United Kingdom. Publicly available evidence describes it as a company in London and identifies it as the developer of the XRAI extended reality software platform for minimally invasive surgical procedures. The supplied sources do not state a founding year, founder, or ownership structure, so the company's early corporate history cannot be reconstructed from the available evidence. What is documented is the company's product direction. Medical iSight states that it is building an Extended Reality software platform for minimally invasive surgical procedures, combining extended reality with artificial intelligence. The platform, XRAI, is described as creating ground-breaking 3D visualisation and guidance software for surgeons performing complex vascular procedures. Interventionalists are given access to new and vital patient data in real time, providing understanding and insight for successful procedures. The company's initial clinical focus is stroke. Medical iSight describes stroke as the second leading cause of disability and the fourth leading cause of death worldwide, and says it is working with leading neuro-interventionalists to enhance mechanical thrombectomy, the highly effective but extremely challenging procedure that retrieves blood clots from vessels in the brain that cause a stroke. The company states that XRAI has numerous applications in a variety of medical disciplines beyond this initial focus. Medical iSight has also described the technical components of its platform, including segmentation, soft tissue deformation and registration algorithms; a kinematic database of surgical techniques; measurable quality improvement benchmarking; and the curation of proprietary data sets that it says develops significant and valuable intellectual property. It claims tool tracking within 0.5 mm accuracy and real-time, image-based guidance. In January 2025, the company's XRAIneuro product received industry visibility when an extract from NVIDIA CEO Jensen Huang's opening video for his keynote speech at CES 2025 included a 10-second clip of XRAIneuro at the start. The company remains privately held according to the available evidence, and no parent company, founder, or founding date is disclosed in the supplied sources.

• A 10-second clip of XRAIneuro appeared at the start of an extract from NVIDIA CEO Jensen Huang's opening video for his keynote speech at CES 2025.

Developer of an Extended Reality and Artificial Intelligence software platform for minimally invasive surgical procedures, initially focused on stroke and mechanical thrombectomy.

• XRAI

  Extended Reality and Artificial Intelligence software platform for minimally invasive surgical procedures, providing 3D visualisation and real-time, image-based guidance for complex vascular procedures.

• XRAIneuro

  A product within the XRAI platform, featured in NVIDIA CEO Jensen Huang's CES 2025 keynote opening video.

1. 1HOME | Medical iSightmedicalisight.com
2. 2Medical iSight (UK) Ltd. (United Kingdom) - Wikidatawikidata.org